Prosecution Insights
Last updated: November 20, 2026
Application No. 18/578,338

USE OF 2,3,6-TRIMETHYL-2-CYCLOHEXEN-1-ONE AS AROMA INGREDIENT

Non-Final OA §102§103§112
Filed
Jan 11, 2024
Priority
Jul 13, 2021 — EU 21185186.0 +1 more
Examiner
ANTHONY, JOSEPH DAVID
Art Unit
1764
Tech Center
1700 — Chemical & Materials Engineering
Assignee
BASF SE
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
79%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
755 granted / 1032 resolved
+8.2% vs TC avg
Moderate +6% lift
Without
With
+5.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
33 currently pending
Career history
1065
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
35.7%
-4.3% vs TC avg
§102
24.9%
-15.1% vs TC avg
§112
24.6%
-15.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1032 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse Group I, claims 16 and 18-20 in the reply filed on 8/21/26 is acknowledged. The traversal is on the ground(s) that 2,3,6-trimethyl-2-cyclohexen-1-one brings about surprising olfactory properties in a composition. This is not found persuasive for the reasons of record that compositions comprising 2,3,6-trimethyl-2-cyclohexen-1-one are well known in art. The requirement is still deemed proper and is therefore made FINAL. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 19 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. It is hard to understand how the various aroma impressions, as set forth in dependent claim 19, are further limiting of 2,3,6-trimethyl-2-cyclohexen-1-one containing compositions since 2,3,6-trimethyl-2-cyclohexen-1-one itself has these various aroma impressions. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 102 Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 16 and 19-20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated Young U.S. Patent Number 3,859,365. Young discloses alkyl-substituted phenols, particularly 3,4,5- and 2,3,6-trimethylphenols, are prepared by heating a suitable alkyl-substituted 2-cyclohexen-1-one in the presence of oxygen, a catalytic amount of cupric chloride, from 0.01 to 2.0 moles of hydrochloric acid and a water compatible organic solvent at a temperature of from 20 to 200.degree.C. The phenols are especially useful as germicidal materials, for conversion into soil insecticidal materials and as intermediates for the synthesis of trimethylhydroquinone, see abstract, examples and claims, such as claim 4. Applicant’s claims are deemed to be anticipate over Example 2 which uses the same process as in Example 1. In Example 2, 2,3,6-trimethyl-2-cyclohexen-1-one is slowly added over a period of 1 hour to a composition comprising a solution of cupric chloride dihydrate, hydrochloric acid, acetic acid and water. The reaction occurs while air is admixed with said composition comprising 2,3,6-trimethyl-2-cyclohexen-1-one over a period of over 2.5 hours to make 2,3,6-trimethyl phenol (the dehydrogenation product of 2,3,6-trimethyl-2-cyclohexen-1-one). Please note that during the 1 hour of the addition of 2,3,6-trimethyl-2-cyclohexen-1-one to the solution/composition, 2,3,6-trimethyl-2-cyclohexen-1-one inherently imparts aroma impressions to the solution/composition. Claim(s) 16 and 19-20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated Thoemel et al. U.S. Patent Number 4,491,545. Thoemel et al. discloses a process of making 2,3,5-trimethyl-p-benzoquinone using either 2,3,6-trimethylcyclohex-2-en-1-one (same compound as Applicant’s 2,3,6-trimethyl-2-cyclohexen-1-one) or 2,5,6-trimethylcyclohex-2-en-1-one. Applicant’s claims are deemed to be anticipated over Examples 1-3 when 2,3,6-trimethylcyclohex-2-en-1-one is used as the starting material instead of 2,5,6-trimethylcyclohex-2-en-1-one. Please note that Example 1 teaches a process of making 2,3,5-trimethyl-p-benzoquinone where a mixture of hydrogen chloride in isopropanol at room temperature is first produced, followed by the addition of 2,5,6-trimethylcyclohex-2-en-1-one and copper(I) oxide. The reaction occurs when said mixture is heated to 70oC and air is admixed with said mixtures over a period of 3 hours. Please note that the substitution of 2,3,6-trimethylcyclohex-2-en-1-one for 2,5,6-trimethylcyclohex-2-en-1-one in said process, would have been at once envisaged since Thoemel et al. directly discloses that either 2,3,6-trimethylcyclohex-2-en-1-one or 2,5,6-trimethylcyclohex-2-en-1-one are used as a starting reactant. Also note that the addition of 2,5,6-trimethylcyclohex-2-en-1-one or 2,3,6-trimethylcyclohex-2-en-1-one, would inherently impart aroma impressions to the starting composition, which subsequently undergoes the reaction to make 2,3,5-trimethyl-p-benzoquinone. Claim(s) 18 and 18-20 are rejected under 35 U.S.C. 102(a)(1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over GB 1,300,431. GB discloses a process for the production of 2,3,6-trimethyl-2-cyclohexen-1-one from starting reactants, see Example 1. Applicant’s claims are deemed to be anticipated over this Example when after the reaction has taken place, an extraction process is performed wherein diethyl ether is added to extract 2,3,6-trimethyl-2-cyclohexen-1-one from the organic layer phase. In the alternative, to perform the extraction step wherein the product composition comprising 2,3,6-trimethyl-2-cyclohexen-1-one, is itself added to a diethyl ether extractant composition, would have been at once envisaged by one having ordinary skill in the art since such would be equally effective and safe to extract the 2,3,6-trimethyl-2-cyclohexen-1-one product. Finally, it is noted that 2,3,6-trimethyl-2-cyclohexen-1-one would inherently impart aroma impressions to extractant composition containing diethyl ether. It is also noted that a composition comprising 2,3,6-trimethyl-2-cyclohexen-1-one in diethyl ether, reads directly on at least a perfume composition as set forth in Applicant’s dependent claim 18. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOSEPH DAVID ANTHONY whose telephone number is (571)272-1117. The examiner can normally be reached M-F: 10:00AM-6:30PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Arrie (Lanee) Reuther can be reached at 571-270-7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOSEPH D ANTHONY/Primary Examiner, Art Unit 1764
Read full office action

Prosecution Timeline

Jan 11, 2024
Application Filed
Nov 04, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12802830
OXIDATION AND CORROSION RESISTANT NUCLEAR FUEL
4y 9m to grant Granted Nov 17, 2026
Patent 12799339
Intumescent coating having improved low-temperature flexibility
4y 0m to grant Granted Nov 17, 2026
Patent 12790497
CORROSION INHIBITOR
4y 6m to grant Granted Nov 10, 2026
Patent 12781061
MODIFIED GRAPHENE AND GRAPHENE NANOPLATELET FOR ANTI-CORROSION COATINGS
4y 2m to grant Granted Nov 03, 2026
Patent 12781126
NON-TRIAZOLE COMPOUNDS AND METHODS FOR INHIBITING CORROSION USING NON-TRIAZOLE COMPOUNDS
3y 2m to grant Granted Nov 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
79%
With Interview (+5.5%)
2y 7m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1032 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month